MAP-6D1 Activators
MAP-6D1 Activators include a range of chemical compounds that directly or indirectly enhance the activity of MAP-6D1, a protein involved in stabilizing microtubules and regulating neuronal plasticity. Phorbol 12-myristate 13-acetate (PMA) and Forskolin lead to the activation of protein kinase C (PKC) and protein kinase A (PKA) respectively. Both PKC and PKA are capable of phosphorylating MAP-6D1 or its interacting partners, leading to enhanced activity in microtubule stabilization. Okadaic acid and Calyculin A are phosphatase inhibitors that prevent the dephosphorylation of proteins, indirectly sustaining MAP-6D1 in a phosphorylated state conducive to its functional activity.
AICAR activates AMP-activated protein kinase (AMPK), which can then phosphorylate MAP-6D1 or its associated proteins, thereby enhancing MAP-6D1's role in microtubule dynamics. In contrast, 5-Azacytidine and Trichostatin A (TSA) act epigenetically.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, as an HDAC inhibitor, leads to histone hyperacetylation that can enhance the expression of proteins that assist MAP-6D1 in its role of microtubule stabilization and dynamics. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that can lead to the accumulation of ubiquitinated proteins, which can indirectly enhance the functional activity of MAP-6D1 by stabilizing proteins that associate with it. | ||||||